Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_assertion description "[A combined prognostic score of tumour budding and CD8(+), FoxP3(+) and CD68(+) distinctly identified patients with low-, moderate- or high-risk colorectal cancers with 5-year survival rates of 75.2% [confidence interval 95% (CI): 66-83], 56.3% (95% CI: 43-68) and 25.2% (95% CI: 14-38), respectively, in MMR-proficient and -deficient cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_assertion evidence source_evidence_literature NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_assertion SIO_000772 22034888 NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_assertion wasDerivedFrom befree-20140225 NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_assertion wasGeneratedBy ECO_0000203 NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP748457.RArv37DmiDa7VkLJe9_RDfebqZRFQXD6m9H1EAIfD3nl0130_provenance.